“The HMI’s findings did not indicate market abuse such as anti-competitive or excessive pricing and profits,” said Koert Pretorius, the chief executive of Mediclinic Southern Africa.
Pretorius said the HMI had also erroneously stated that the three leading private hospital groups were able to distort and prevent competition by binding the best medical specialists to their hospitals with lucrative inducement programmes.
“Mediclinic supports cost-effective quality care and does not condone any treatment that is not in the best interests of the patient,” he said.
Pretorius said Mediclinic did not condone any relationships between hospitals and doctors that did not meet their high ethical code of conduct. “It is important to note that the market context has moved on since 2014; the end date for the majority of data used,” he said.